恩帕吉菲
医学
达帕格列嗪
二羟基化合物
2型糖尿病
泌尿科
内科学
糖尿病
重症监护医学
内分泌学
环氧树脂
有机化学
化学
双酚A
作者
Kasper Bonnesen,Uffe Heide‐Jørgensen,Diana Hedevang Christensen,Christian Fynbo Christiansen,Timothy L. Lash,Sean Hennessy,Anthony Matthews,Lars Pedersen,Reimar W. Thomsen,Morten Schmidt
标识
DOI:10.1001/jamainternmed.2024.7381
摘要
The results of this cohort study suggest that people with type 2 diabetes who initiated treatment with empagliflozin and dapagliflozin had comparable long-term kidney outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI